Herbas VPB

Print
EN | LT
LT - Afikamteno dozavimo režimai, skirti obstrukcinės hipertrofinės kardiomiopatijos gydymui
EN - AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4245 (2006.01)
A61K 31/4402 (2006.01)
A61K 45/06 (2006.01)
A61P 9/00 (2006.01)
A61K 9/00 (2006.01)
European patent
(11) Number of the document 4370116
(13) Kind of document T
(96) European patent application number 22753953.3
Date of filing the European patent application 2022-07-15
(97) Date of publication of the European application 2024-05-22
(45) Date of publication and mention of the grant of the patent 2025-01-15
(46) Date of publication of the claims translation 2025-04-10
PCT application
(86) Number PCT/US2022/073808
Date 2022-07-15
PCT application publication
(87) Number WO 2023/288324
Date 2023-01-19
Priority applications
(30) Number Date Country code
202163203333 P 2021-07-16 US
202263299753 P 2022-01-14 US
202263305609 P 2022-02-01 US
202263331197 P 2022-04-14 US
202263343975 P 2022-05-19 US
Inventors
(72)
MALIK, Fady , US
KUPFER, Stuart , US
HEITNER, Stephen B. , US
ROBERTSON, Laura Ann , US
MENG, Lixin , US
OSMUKHINA, Anna , US
WOHLTMAN, Qi , US
Grantee
(73) Cytokinetics, Inc. , 350 Oyster Point Blvd, South San Francisco CA 94080, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Afikamteno dozavimo režimai, skirti obstrukcinės hipertrofinės kardiomiopatijos gydymui
  AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Last renewal fee
Payment date Validity (years) Amount
2025-06-23 4 92.00 EUR
Next renewal fee
2026-07-15